[1] |
MA Hongyang, YUE Anna, SUN Kangyun.
Familial Hypercholesterolemia: Diagnostic Differences between Domestic and Foreign Guidelines
[J]. Chinese General Practice, 2025, 28(06): 655-665.
|
[2] |
CHEN Chao, CHEN Tianxiang, LIU Qianwei, ZHANG Zhi, WANG Huanhuan, WU Pingping, GAO Lei, YU Zhaoxiang.
Analysis and Identification of Hub Genes in Hepatocellular Carcinoma Based on Weighted Gene Co-expression Network and Cancer Genome Atlas Clinical Data
[J]. Chinese General Practice, 2024, 27(32): 4050-4059.
|
[3] |
ZHANG Lin, GAO Jin, WU Minghua, WANG Guangmei.
Clinical Efficacy and Mechanism of Action of Tongnao Decoction Treating Acute Cerebral Infarction: a Study Based on Network Pharmacology and Molecular Docking
[J]. Chinese General Practice, 2024, 27(23): 2904-2912.
|
[4] |
KANG Yinnan, SHI Jiaqi, WANG Junke, LI Bin, LI Chuyi, MA Jun, YU Xiaohui.
Advances in the Application of Antibody Drug Conjugate in Gastric Cancer with Low Expression of Human Epidermal Growth Factor Receptor 2
[J]. Chinese General Practice, 2024, 27(18): 2287-2294.
|
[5] |
DIAO He, BAI Wenpei, ZHAO Lidong.
Chemical Composition and Mechanism of Zuoci Pill in Treating Perimenopausal Hearing Loss Based on Network Pharmacology and Molecular Docking Technology
[J]. Chinese General Practice, 2024, 27(12): 1493-1503.
|
[6] |
ZHANG Shuai, LI Na, SHEN Jiangli, LIU Yuedong, WU Xianshu, WANG Lei, SHENG Tianjiao, XU Hongjun, AN Shengjun.
Effect and Mechanism of Optimized Kuijie Decoction in Ulcerative Colitis Rats with TCM Syndrome Differentiation of Qi Stagnation and Blood Stasis
[J]. Chinese General Practice, 2024, 27(11): 1356-1362.
|
[7] |
PEI Bei, CHENG Lin, XU Lingyun.
Effects of Different Neoadjuvant Chemotherapy Regimens on Immune Indicators and Tumor Microenvironment in HER-2-positive Breast Cancer Patients
[J]. Chinese General Practice, 2023, 26(27): 3435-3440.
|
[8] |
LAO Shen, HE Jianxing, LIANG Wenhua.
Targeting Pericytes for Vascular Normalization as an Emerging Strategy in Remodeling Tumor Microenvironment
[J]. Chinese General Practice, 2022, 25(32): 3971-3977.
|
[9] |
Ziqiang HONG, Dacheng JIN, Xiangdou BAI, Baiqiang CUI, Yunjiu GOU.
Recent Advances in the Diagnosis and Management of Multiple Primary Lung Cancer
[J]. Chinese General Practice, 2022, 25(27): 3435-3442.
|
[10] |
Writing Group for the Expert Consensus on Immunomodulatory Therapies for Chronic Obstructive Pulmonary Disease.
Expert Consensus on Immunomodulatory Therapies for Chronic Obstructive Pulmonary Disease
[J]. Chinese General Practice, 2022, 25(24): 2947-2959.
|
[11] |
Yan YU, Chunai WANG, Xiaoyu QIN, Yulan LI, Xi LIANG, Xiaohui WEN, Min LIU.
Effect and Mechanism of Action of Acupoint Injection of Puerarin on Myocardial Mitochondria Energy Metabolism in Bupivacaine-poisoned Rats
[J]. Chinese General Practice, 2022, 25(18): 2280-2285.
|
[12] |
Kun YE, Min LEI, Xin XIE, Hui ZHENG, Min CHEN, Shuguang YU.
Mechanism of Huangqi Jianzhong Decoction in Treating Diarrhea Predominant Irritable Bowel Syndrome Based on Network Pharmacology and Molecular Docking Technology
[J]. Chinese General Practice, 2022, 25(15): 1814-1824.
|
[13] |
SUN Kai,ZHU Liguo,WEI Xu,YIN He,LI Qiuyue,QIN Xiaokuan,YANG Bowen1.
Chemical Constituents of Zhuangyaotongluo Decoction and Its Mechanism of Action in Delaying the Progression of Lumbar Intervertebral Disc Degeneration: a Study Using UPLC-Q-TOF-MS/MS and Network Pharmacology
[J]. Chinese General Practice, 2021, 24(35): 4437-4446.
|
[14] |
CHEN Xuefeng,RONG Chunli,YAO Wenjing,ZHANG Yantao,BAI Wenlou,JIA Yongjian,HAO Ziqiang,QI Xiaoyong.
Novel Advances in the Mechanism of Cardiovascular Benefit of Sodium-glucose Co-transporter 2 Inhibitors
[J]. Chinese General Practice, 2021, 24(3): 272-279.
|
[15] |
SONG Yuzhi,ZHEN Chanjun,BAI Wenwen,LI Bo,QIAO Xueying,ZHOU Zhiguo.
Intracranial Failure Analysis in Patients with Brain Metastasis from Lung Adenocarcinoma Harboring Epidermal Growth Factor Receptor Mutation
[J]. Chinese General Practice, 2021, 24(29): 3704-3710.
|